Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$72.54 - $95.56 $29,161 - $38,415
-402 Reduced 9.7%
3,741 $357,000
Q2 2023

Jul 11, 2023

SELL
$81.41 - $94.33 $63,499 - $73,577
-780 Reduced 15.84%
4,143 $390,000
Q1 2023

Apr 24, 2023

SELL
$74.26 - $84.51 $82,651 - $94,059
-1,113 Reduced 18.44%
4,923 $407,000
Q4 2022

Jan 11, 2023

BUY
$68.3 - $87.44 $3,005 - $3,847
44 Added 0.73%
6,036 $0
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $494,384 - $643,954
-6,002 Reduced 50.04%
5,992 $495,000
Q2 2022

Jul 21, 2022

SELL
$86.5 - $128.27 $2,162 - $3,206
-25 Reduced 0.21%
11,994 $1.14 Million
Q1 2022

Apr 28, 2022

SELL
$101.96 - $128.34 $336,977 - $424,163
-3,305 Reduced 21.57%
12,019 $1.42 Million
Q4 2021

Jan 18, 2022

SELL
$106.37 - $130.68 $22,763 - $27,965
-214 Reduced 1.38%
15,324 $1.99 Million
Q3 2021

Oct 26, 2021

SELL
$102.91 - $122.75 $165,890 - $197,873
-1,612 Reduced 9.4%
15,538 $1.76 Million
Q2 2021

Aug 03, 2021

SELL
$83.84 - $104.76 $39,404 - $49,237
-470 Reduced 2.67%
17,150 $1.78 Million
Q1 2021

Apr 29, 2021

BUY
$78.68 - $90.67 $93,865 - $108,169
1,193 Added 7.26%
17,620 $1.47 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $53,767 - $68,422
750 Added 4.78%
16,427 $1.5 Million
Q3 2020

Oct 19, 2020

BUY
$67.19 - $87.44 $29,093 - $37,861
433 Added 2.84%
15,677 $1.25 Million
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $562,453 - $752,186
9,775 Added 178.73%
15,244 $1.05 Million
Q1 2020

Apr 09, 2020

SELL
$52.41 - $81.0 $12,368 - $19,116
-236 Reduced 4.14%
5,469 $1.03 Million
Q4 2019

Feb 04, 2020

BUY
$71.7 - $82.09 $46,246 - $52,948
645 Added 12.75%
5,705 $1.33 Million
Q3 2019

Oct 15, 2019

SELL
$61.55 - $75.43 $27,512 - $33,717
-447 Reduced 8.12%
5,060 $1.11 Million
Q2 2019

Jul 11, 2019

BUY
$55.74 - $64.41 $5,574 - $6,441
100 Added 1.85%
5,507 $1.02 Million
Q4 2018

Jan 25, 2019

BUY
$46.41 - $56.94 $250,938 - $307,874
5,407 New
5,407 $828,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Legacy Bridge, LLC Portfolio

Follow Legacy Bridge, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Bridge, LLC with notifications on news.